ATRX fundamentals
An in-depth look to Adhera Therapeutics Inc. operating, investing, and financing activities
ATRX free cash flow for Q3 23 is -13.45 k USD. For 2022, ATRX free cash flow was -1.42 M USD and operating cash flow was -1.42 M USD.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM